drugset / Trial / NCT06074562
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to determine the safety and efficacy of LY3556050 versus placebo in participants with diabetic peripheral neuropathic pain (DPNP). The study will lasts approximately 24 weeks, across 3 study periods.
Timeline
- Start
- 2023-10-05
- Primary completion
- 2025-06-11
- Completion
- 2025-06-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3556050 | Unknown | — | Oral |